These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16094092)

  • 41. Leptospirosis and Jarisch-Herxheimer reaction.
    Takamizawa S; Gomi H; Shimizu Y; Isono H; Shirokawa T; Kato M
    QJM; 2015 Dec; 108(12):967-8. PubMed ID: 25862773
    [No Abstract]   [Full Text] [Related]  

  • 42. Hepatocellular enzyme elevations in a patient receiving ceftriaxone.
    Rivkin AM
    Am J Health Syst Pharm; 2005 Oct; 62(19):2006-10. PubMed ID: 16174837
    [No Abstract]   [Full Text] [Related]  

  • 43. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
    Torres A; Garau J; Arvis P; Carlet J; Choudhri S; Kureishi A; Le Berre MA; Lode H; Winter J; Read RC;
    Clin Infect Dis; 2008 May; 46(10):1499-509. PubMed ID: 18419482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid formation of large pseudostones and acute cholangitis caused by ceftriaxone treatment for bacterial pneumonia in a patient on kidney transplantation: potential risk of ceftriaxone use in patients with decreased kidney function.
    Yamada S; Takesako M; Nakano T; Tsuruya K; Kitazono T
    CEN Case Rep; 2020 Feb; 9(1):87-88. PubMed ID: 31531767
    [No Abstract]   [Full Text] [Related]  

  • 45. Ceftriaxone-induced biliary sludge in a patient with uncontrolled diabetes.
    Hagiya H; Hasegawa K; Asano K; Otsuka F
    Intern Med; 2014; 53(21):2549-50. PubMed ID: 25366021
    [No Abstract]   [Full Text] [Related]  

  • 46. Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events.
    Bradley JS; Wassel RT; Lee L; Nambiar S
    Pediatrics; 2009 Apr; 123(4):e609-13. PubMed ID: 19289450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ceftriaxone as prophylaxis in endourology and extracorporal shockwave lithotripsy (ESWL).
    Kühn W; Michaelis F; Bortfeld S; Weissbach L
    J Chemother; 1989 Jul; 1(4 Suppl):1015-6. PubMed ID: 16312750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Ceftriaxone-associated biliary pseudolithiasis in a child with nephrotic syndrome].
    Zheng FY; Xing Y; Lu S; Liu DM
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):696-7. PubMed ID: 23965889
    [No Abstract]   [Full Text] [Related]  

  • 49. The comparison of single-dose ceftriaxone, five-day azithromycin, and ten-day amoxicillin/clavulanate for the treatment of children with acute otitis media.
    Biner B; Celtik C; Oner N; Küçükuğurluoğlu Y; Güzel A; Yildirim C; Adali MK
    Turk J Pediatr; 2007; 49(4):390-6. PubMed ID: 18246740
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pediatric implications of antibiotic therapy].
    József I
    Orv Hetil; 1988 Jul; 129(29):1562. PubMed ID: 3174111
    [No Abstract]   [Full Text] [Related]  

  • 51. Research Progress of Mechanisms of Ceftriaxone Associated Nephrolithiasis.
    Wang S; Huang X; Xu Q; Xu T
    Mini Rev Med Chem; 2017; 17(17):1584-1587. PubMed ID: 27488586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ceftriaxone-associated biliary pseudolithiasis in a child].
    Wang YQ
    Zhonghua Er Ke Za Zhi; 2005 Apr; 43(4):251. PubMed ID: 15924712
    [No Abstract]   [Full Text] [Related]  

  • 53. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.
    Miro JM; Cervera C; Garcia-de-la-Maria C; Del Rio A; Armero Y; Mestres CA; Grau JM; Marco F; Moreno A
    Scand J Infect Dis; 2008; 40(11-12):968-72. PubMed ID: 18767002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prospective study of ceftriaxone treatment in acute pyelonephritis caused by extended-spectrum beta-lactamase-producing bacteria.
    Suankratay C; Jutivorakool K; Jirajariyavej S
    J Med Assoc Thai; 2008 Aug; 91(8):1172-81. PubMed ID: 18788687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia.
    Pertel PE; Bernardo P; Fogarty C; Matthews P; Northland R; Benvenuto M; Thorne GM; Luperchio SA; Arbeit RD; Alder J
    Clin Infect Dis; 2008 Apr; 46(8):1142-51. PubMed ID: 18444848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
    Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Anaphylactoid shock or precipitation of calcium-ceftriaxone in a premature newborn. A case report].
    Belliard CR; Sibille G
    Arch Pediatr; 2007 Feb; 14(2):199-200. PubMed ID: 17166703
    [No Abstract]   [Full Text] [Related]  

  • 58. Ceftriaxone induced thrombocytopenia in a child.
    Akbayram S; Akgun C; Dogan M; Caksen H; Oner AF
    Bratisl Lek Listy; 2011; 112(2):97-8. PubMed ID: 21456510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple Drugs Causing Severe Anemia in Infective Endocarditis.
    Singh A; Shetty PN; Singh BM; Devasia T
    Cardiovasc Hematol Disord Drug Targets; 2016; 16(1):3-5. PubMed ID: 27215287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Life-threatenting ceftriaxone-induced immune hemolytic anemia in a child with Crohn's disease.
    Mattis LE; Saavedra JM; Shan H; Shirey RS; Powell E; Oliva-Hemker MM
    Clin Pediatr (Phila); 2004 Mar; 43(2):175-8. PubMed ID: 15024441
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.